Protein kinase C activation contributes to microvascular barrier dysfunction in the heart at early stages of diabetes.
about
alpha2-Heremans Schmid glycoprotein, a putative inhibitor of tyrosine kinase, prevents glucose toxicity associated with cardiomyocyte dysfunctionVE-cadherin and beta-catenin binding dynamics during histamine-induced endothelial hyperpermeabilityEnhanced permeability responses to inflammation in streptozotocin-induced diabetic rat venules: Rho-mediated alterations of actin cytoskeleton and VE-cadherinRnd3 as a Novel Target to Ameliorate Microvascular LeakageLarge-scale elucidation of drug response pathways in humansAdenosine A2A receptor modulation of juvenile female rat skeletal muscle microvessel permeabilityADAM15 regulates endothelial permeability and neutrophil migration via Src/ERK1/2 signallingMyosin light chain kinase in microvascular endothelial barrier function.Ascorbic acid prevents high glucose-induced apoptosis in human brain pericytes.Differential coronary microvascular exchange responses to adenosine: roles of receptor and microvessel subtypesSubcellular proteomic approach for identifying the signaling effectors of protein kinase C-β₂ under high glucose conditions in human umbilical vein endothelial cellsMolecular mechanism of edema formation in nephrotic syndrome: therapeutic implications.A role for the endothelial glycocalyx in regulating microvascular permeability in diabetes mellitus.Myosin light chain kinase signaling in endothelial barrier dysfunction.Mst1 inhibits CMECs autophagy and participates in the development of diabetic coronary microvascular dysfunction.Molecular mechanisms of endothelial hyperpermeability: implications in inflammation.Ascorbate reverses high glucose- and RAGE-induced leak of the endothelial permeability barrierInterplay between FAK, PKCδ, and p190RhoGAP in the regulation of endothelial barrier function.ADAM-15 disintegrin-like domain structure and function.Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.Modulation of endothelial glycocalyx structure under inflammatory conditions.Role of protein kinase C isoforms in rat epididymal microvascular endothelial barrier function.Temporal development of retinal arteriolar endothelial dysfunction in porcine type 1 diabetesModulation of endothelial permeability by 1-O-alkylglycerols.Counter regulatory effects of PKCbetaII and PKCdelta on coronary endothelial permeability.A PKC-beta inhibitor protects against cardiac microvascular ischemia reperfusion injury in diabetic rats.Protein kinase C-beta II Is an apoptotic lamin kinase in polyomavirus-transformed, etoposide-treated pyF111 rat fibroblasts.Src-dependent, neutrophil-mediated vascular hyperpermeability and beta-catenin modification.VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide.Upregulation of PKC genes and isozymes in cardiovascular tissues during early stages of experimental diabetes.Involvement of PKCdelta and PKD in pulmonary microvascular endothelial cell hyperpermeability.Inhibitory effect of hypocrellin A on protein kinase C in liver and skeletal muscle of obese Zucker rats.Improvement in cardiac function of diabetic rats by bosentan is not associated with changes in the activation of PKC isoforms.Protein kinase C family members as a target for regulation of blood-brain barrier Na,K,2Cl-cotransporter during in vitro stroke conditions and nicotine exposure.Rottlerin causes pulmonary edema in vivo: a possible role for PKCdelta.A novel assay provides sensitive measurement of physiologically relevant changes in albumin permeability in isolated human and rodent glomeruli.
P2860
Q24305541-7920FC40-7D99-48B6-A57F-C6F7AAD110E7Q24315783-083FBCCE-872F-4271-AFD2-E94BEE7E1DF6Q28389324-690732FF-2EF6-4FE6-BB59-4B29C1E8E767Q28393903-0B97CD3B-4972-4D39-B9D4-8C90579EC4B4Q28480519-23DF7A77-AE69-446A-83FC-A8E7908465B0Q28565968-FC79CF10-4FCA-4BFF-A09D-3F1C0B227168Q33954946-BB458A22-8618-46D8-84FA-A12B082E4177Q33954983-EB9D210D-8D34-46A1-8ACC-00B72211AD24Q34205310-7498261B-3E95-47A7-B39A-88A24A522E53Q35944215-0B830F65-1D0B-4B5A-A248-096CF4CF9AD3Q36224900-4502D88B-47B0-4668-98FF-A1DDE73590F1Q36842473-7708DDCC-BA75-4E44-8D43-16A8C3A99686Q36955995-6B53C9B4-C3C2-4C6C-A639-30437CA9BC43Q37076073-E49E5FF1-C2F0-4B1A-9B10-481BCF4BC13AQ37293755-B275C29C-3049-481B-896B-C039287CF0DAQ37535022-57E81E56-C07B-481A-AEFC-1964CFA2641FQ37639110-BDBD03C6-794C-408D-A881-64C8351B2EB6Q37872833-0736A638-95BB-4093-A9F2-D3B7C5B9E1BEQ37954269-D768391C-2F11-4BD6-BB37-A5CB1541C919Q38083574-9F5C58F7-E933-4D36-B7C1-14D39BFDC7B5Q38209920-BD35F3C6-7BD1-4942-AC01-82EF93099355Q40653322-DA9F5669-3471-4C78-8D8C-6EE9D7BB755AQ42382660-7756BA77-606D-4538-BAD0-55F4D1077862Q42528056-80D22554-39B0-476E-82E5-F949D85DDD70Q43198819-A7E9628D-90C4-4738-9840-CE4307EEF779Q43203675-ADE367AC-ADA5-49C2-91D0-E3E246E53B46Q43921988-F1FFBA12-E326-4ACD-BD4C-0EE44FACB504Q44185227-1E2E0ECB-E91C-41F1-8EA2-D7ACD573AC9BQ44185678-487D69AC-540E-48AB-BE7B-0D356D255B1DQ44222544-5A99E60E-2704-4A88-BE17-7CA2E3638697Q44588542-3669EBC4-C80F-4393-A289-ED71DCFFBBDFQ44781647-6BD8B098-98B6-4378-9D23-C8947676ED7FQ46827561-88DCA273-2232-4D31-8B4E-265F57515E47Q46921982-590AD0FD-0563-41D4-9840-EB19C04A0ABDQ46977319-EE1C7A4E-001E-4D56-B575-6497A9F3B688Q50056716-27849B8F-0A5C-47D1-9AEF-5BFD5224037B
P2860
Protein kinase C activation contributes to microvascular barrier dysfunction in the heart at early stages of diabetes.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Protein kinase C activation co ...... t at early stages of diabetes.
@en
Protein kinase C activation co ...... t at early stages of diabetes.
@nl
type
label
Protein kinase C activation co ...... t at early stages of diabetes.
@en
Protein kinase C activation co ...... t at early stages of diabetes.
@nl
prefLabel
Protein kinase C activation co ...... t at early stages of diabetes.
@en
Protein kinase C activation co ...... t at early stages of diabetes.
@nl
P2093
P356
P1433
P1476
Protein kinase C activation co ...... t at early stages of diabetes.
@en
P2093
Korompai FL
Taulman AC
Tinsley JH
Ustinova EE
P304
P356
10.1161/01.RES.87.5.412
P577
2000-09-01T00:00:00Z